These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31779564)

  • 1. Demystifying Smoker's Paradox: A Propensity Score-Weighted Analysis in Patients Hospitalized With Acute Heart Failure.
    Doi SA; Islam N; Sulaiman K; Alsheikh-Ali AA; Singh R; Al-Qahtani A; Asaad N; AlHabib KF; Al-Zakwani I; Al-Jarallah M; AlMahmeed W; Bulbanat B; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Panduranga P; Shehab A; Al Suwaidi J; Salam AM
    J Am Heart Assoc; 2019 Dec; 8(23):e013056. PubMed ID: 31779564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Nunez E; Yancy CW; Young JB
    Eur Heart J; 2008 Aug; 29(16):1983-91. PubMed ID: 18487210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a 'smoker's paradox' in field triaged ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Allahwala UK; Murphy JC; Nelson GI; Bhindi R
    Cardiovasc Revasc Med; 2013; 14(4):213-7. PubMed ID: 23856073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitating Factors for Hospitalization with Heart Failure: Prevalence and Clinical Impact Observations from the Gulf CARE (Gulf aCute heArt failuRe rEgistry).
    Salam AM; Sulaiman K; Alsheikh-Ali AA; Singh R; AlHabib KF; Al-Zakwani I; Asaad N; Al-Qahtani A; Al-Jarallah M; AlMahmeed W; Bulbanat B; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Panduranga P; AlFaleh H; Shehab A; Al Suwaidi J
    Med Princ Pract; 2020; 29(3):270-278. PubMed ID: 31522185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in left ventricular systolic function in patients with ST elevation myocardial infarction: Evidence for smoker's paradox or pseudo-paradox?
    Acar B; Ozeke O; Unal S; Karakurt M; Kara M; Kirbas O; Sen F; Korkmaz A; Aras D; Aydogdu S
    Indian Heart J; 2016; 68(6):816-820. PubMed ID: 27931553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East.
    Abi Khalil C; Sulaiman K; Mahfoud Z; Singh R; Asaad N; AlHabib KF; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Faleh HA; Elasfar A; Panduranga P; Suwaidi JA;
    BMJ Open; 2017 Jul; 7(7):e014915. PubMed ID: 28694343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "smoker's paradox" in patients with acute coronary syndrome: a systematic review.
    Aune E; Røislien J; Mathisen M; Thelle DS; Otterstad JE
    BMC Med; 2011 Aug; 9():97. PubMed ID: 21861870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Smoker's paradox' in young patients with acute myocardial infarction.
    Chen KY; Rha SW; Li YJ; Jin Z; Minami Y; Park JY; Poddar KL; Ramasamy S; Wang L; Li GP; Choi CU; Oh DJ; Jeong MH;
    Clin Exp Pharmacol Physiol; 2012 Jul; 39(7):630-5. PubMed ID: 22551379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of smoking on survival after myocardial infarction - smoker's paradox in Hungary?].
    El-Meouch NM; Ferenci T; Jánosi A
    Orv Hetil; 2018 Apr; 159(14):557-565. PubMed ID: 29611752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
    Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Smoker's Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials.
    Yadav M; Mintz GS; Généreux P; Liu M; McAndrew T; Redfors B; Madhavan MV; Leon MB; Stone GW
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1941-1950. PubMed ID: 31521646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking in acute coronary syndromes--the "smoker's paradox" revisited.
    Gaspar A; Nabalis S; Rocha S; Torres M; Pinto J; Azevedo P; Brandăo A; Pereira MA; Correia A
    Rev Port Cardiol; 2009 Apr; 28(4):425-37. PubMed ID: 19634499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial function and soluble endoglin in smokers with heart failure.
    Heffernan KS; Kuvin JT; Patel AR; Karas RH; Kapur NK
    Clin Cardiol; 2011 Dec; 34(12):729-33. PubMed ID: 22120636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; AlHabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Elasfar A; Panduranga P; Al Suwaidi J
    BMJ Open; 2015 Apr; 5(4):e007148. PubMed ID: 25908674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    Redfors B; Furer A; Selker HP; Thiele H; Patel MR; Chen S; Udelson JE; Ohman EM; Eitel I; Granger CB; Maehara A; Kirtane AJ; Généreux P; Jenkins PL; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2020 Apr; 75(15):1743-1754. PubMed ID: 32299585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.
    Bossard M; Granger CB; Tanguay JF; Montalescot G; Faxon DP; Jolly SS; Widimsky P; Niemela K; Steg PG; Natarajan MK; Gao P; Fox KAA; Yusuf S; Mehta SR
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29101117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study.
    Gupta R; Kirtane AJ; Liu Y; Crowley A; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e007982. PubMed ID: 31672031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of smoking on mortality after acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a retrospective cohort outcome study at 3 years.
    Steele L; Palmer J; Lloyd A; Fotheringham J; Iqbal J; Grech ED
    J Thromb Thrombolysis; 2019 May; 47(4):520-526. PubMed ID: 30666553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.